This study demonstrates that gentamicin ototoxicity depends on dietary
factors and correlates with tissue glutathione levels. After 15 days
of gentamicin injections (100 mg/kg/day s.c.) guinea pigs on a regular
protein diet (18.5% protein) had an average hearing loss of 9 dB at 3
kHz, 31 dB at 8 khz and 42 dB at 18 kHz. Guinea pigs on a 7% protein
diet showed an increased hearing loss of 52 dB at 3 kHz, 63 dB at 8 kH
z and 74 dB at 18 kHz. Supplementing the low protein diet with either
essential or sulfur-containing amino acids did not protect against gen
tamicin ototoxicity. Glutathione levels in the cochlear sensory epithe
lium were decreased in animals on a low protein diet and could be rest
ored to normal by oral administration of glutathione monoethyl ester (
1.2 g/kg/day) in combination with vitamin C (100 mg/kg/day). Glutathio
ne supplementation significantly reduced the magnitude of hearing loss
in the low protein diet group at all frequencies (43 dB reduction at
3 kHz, 27 dB reduction at 8 kHz and 21 dB reduction at 18 kHz). In ani
mals on a full protein diet, dietary glutathione neither increased coc
hlear glutathione levels nor attenuated hearing loss. Serum gentamicin
levels did not differ between animals on the various diets with or wi
thout glutathione supplement. These results suggest that gentamicin to
xicity and detoxifying mechanisms are affected by the metabolic state
of the animal and the glutathione content of the tissue. Thus, compoun
ds that could potentially protect against gentamicin ototoxicity may b
e more correctly assessed in animal models of deficient nutritional st
ates in which endogenous detoxifying mechanisms are compromised. This
animal model might also be more realistically related to the clinical
situation of a critically ill patient receiving gentamicin treatment.